'Make it 20' this Christmas

The challenge was created to celebrate 20 wonderful years of the Jane Tomlinson Appeal, which was founded to continue the legacy of the inspirational Jane Tomlinson to help children live happier and healthier lives and improve the lives of people living with cancer. To mark this significant milestone, we launched the ‘Make it 20’ challenge. The concept was simple; encouraging people to pick an activity, do it 20 times and then ask their friends, family, neighbours etc to do the same and raise money for the Jane Tomlinson Appeal whilst doing so.


As we get to Christmas, it can be a difficult time for families dealing with grief and your donations to the ‘Make it 20’ challenge could help make a difference to those most in need. Your donation will also allow us to actively improve the lives of people with cancer and the health and happiness of youngsters - meaning Christmas is a joyous time for them too. Here’s just an example of how your donations make a real difference: 



It couldn’t be easier to donate as you can make a donation now through our website on behalf of yourself or your business/organisation.


Please help us continue the legacy of our inspiration, Jane Tomlinson CBE.

More news


Kinesio Study Days - want to learn something new in 2024?

Donations to the Jane Tomlinson Appeal fund Kinesio Taping study days, a full day of training where attendees share insights into this therapy together with 1-2-1 demonstrations of applying the tape, and an instruction manual to keep for further study and reference. Study days are free of charge for physiotherapists, nurses or other NHS practitioners. If you’re interested in learning a new, potentially life-enhancing skill, please get in touch with our team to learn more. You can email us at info@janetomlinsonappeal.com.


Teaching Kinesio Taping techniques – Study Days

As you may already know, we split our funding across four core pillars at the Jane Tomlinson Appeal. One of those is research into Kinesio Taping to explore the benefits of the treatment to cancer patients.

View news